home All News open_in_new Full Article

Novo Nordisk shares fall on latest trial results for new obesity drug

Participants with type 2 diabetes had an average weight loss of 15.7 per cent after 68 weeks on CagriSema


today 5 h. ago attach_file Events

attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events


ID: 3259970287
Add Watch Country

arrow_drop_down